PubMed HealthSearch

PubMed · 2487608

Second transplants.

Abstract

1. One-year graft survival for recipients of second cadaver renal allografts was 66%, 10% below that of first transplant recipients. The poor second graft survival rates have not improved since the introduction of cyclosporine A in 1984. 2. The major difference between first and second transplants was a higher rate of immunological failures in the first 3 months. Whether or not the second transplant functioned on the first day was a good indication of the outcome. 3. The degree of HLA mismatching in the first transplant affected second graft survival. When there were no HLA-B,DR mismatches in the first transplant, 1-year second graft survival was 72% compared to 66% when there were mismatches. 4. HLA-A,B,DR matching in the second transplant also improved second graft survival from 65% for completely mismatched grafts to 78% when there were no antigens mismatched. 5. The duration of the first transplant was an important consideration in second graft survival. When the first transplant had functioned for more than 1 year, second graft survival was 74%. When the first graft had been lost within 3 months, second graft survival was less than 60%. 6. Early second graft function in patients whose first transplant had functioned more than 6 months paralleled that of first transplant recipients. When the first transplant was lost within 6 months, 30% of second transplants never functioned or were lost in the first month. With a longer duration first graft, only 10% were lost in the first month. 7. Sensitization, though a predictive factor of second graft survival, was less informative than the first transplant duration.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Yanagiya, J M Cecka. 1989. Second transplants.. https://pubmed.ncbi.nlm.nih.gov/2487608/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Autologous blood transfusion in Auckland.

AIMS: To review autologous blood collection and transfusion practice in Auckland over the last five years. METHOD: Records of autologous blood collections were obtained from blood collection centre records and results of transfusions on patients from hospital notes. RESULTS: One hundred and sixty-four units of blood were collected from 77 patients. Seventy-five percent of the units collected were transfused. Most autologous blood was transfused to private hospital patients. Only 8% of patients required homologous blood. CONCLUSIONS: There has been a slow increase of autologous blood collection and transfusion in the Auckland area, as well as in the rest of New Zealand. The present risks of homologous transfusion, particularly since the introduction of hepatitis C testing, appear very low. A further expansion of the present autologous blood programme would entail increased expenditure and it is suggested that a critical cost benefit analysis would be useful before the programme is expanded.

Blood Transfusion